ÖSTROJEN RESEPTÖRÜ NEGATİF İNVAZİV MEME ...

8) KAYNAKLAR
1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden:
Globocan 2000. Int J Cancer. 2001; 94: 153-156.
2. Burget R, Tuncer , Bozdemi N. Türkiye’de kanser sıkılı ı. Çukurova Üniversitesi
Tıp Fakültesi Dergisi.1994; 38-39.
3. Gusterson A.B,Ross T.D, Heath J.V,Stein T.Basal cytokeratins and their
relationship to the cellular origin and functional classification of breast
cancer.Breast cancer reseach 2005,7:143-148.
4. Rosai J. Ackerman’s Surgical Pathology, 8th ed. Vol II St. Louis, Mosby,
1996;565-1660
5. Rakha A.E, El Sayed E.A, Green R.A, Lee H.S.A .et al.Prognostic markers in
Triple –Negative Breast Cancers.Cancer.January, 2007.Vol.109/number1.
6. Putti TC, Abd El-Rehim DM,A Rakha E et al. Etsrogen receptor- negative breast
carcinomas :a review of morphology and immunophenotypical analysis.Modern
pathology (2005) 18,26-35.
7. Gudjonsson T, Adriance C.M, Sternlicht M.D et al. Myoepithelial cells : Their
origin and Function in Breast Morphogenesis and Neoplasia. Journal of Mammary
gland biology and neoplasia, Vol.10, No.3, July 2005.
8. Hanneman J, Lee H.S, et al.Br J Cancer. 2006. Nov 20; 95(10). 1334-41
9. Fulford LG, Easton DF, Reis- Filho JS, et al. Specific morphological features
predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.
Histopathology 2006, 49, 22-34.
75